Strimvelis, the Ex-vivo stem cell gene therapy to treat ADA-SCID




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Strimvelis, the Ex-vivo stem cell gene therapy to treat ADA-SCID
Released on: August 21, 2017. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Children born with ADA-SCID do not develop a healthy immune system so cannot fight off everyday infections, which results in severe and life-threatening illness.
  • Summary
  • Transcript
  • Participants
  • Company
Children born with ADA-SCID do not develop a healthy immune system so cannot fight off everyday infections, which results in severe and life-threatening illness. Without prompt treatment, the disorder often proves fatal within the child’s first year of life. ADA-SCID is estimated to occur in approximately 15 patients per year in Europe. Emily Culme-Seymour of GSK talks to Summer Park about Strimvelis, the Ex-vivo stem cell gene therapy to treat ADA-SCID, at ISCT 2017
Children born with ADA-SCID do not develop a healthy immune system so cannot fight off everyday infections, which results in severe and life-threatening illness. Without prompt treatment, the disorder often proves fatal within the child’s first year of life. ADA-SCID is estimated to occur in approximately 15 patients per year in Europe. Emily Culme-Seymour of GSK talks to Summer Park about Strimvelis, the Ex-vivo stem cell gene therapy to treat ADA-SCID, at ISCT 2017
Emily Culme-Seymour
GlaxoSmithKline (GSK)
GSK is the world's second largest pharmaceutical company, by employees; and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.